OmniAb OABI
NASDAQ OABI
$4.53 -0.22 (-4.74%)
As of: Sep 4, 2026 · 11:50 AM EDT

OmniAb (OABI) EPS (Diluted) (2021 - 2026)

Analysis

OmniAb (OABI) EPS (Diluted) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 140.22 Bn 132.37 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 86.04 Bn 78.05 Bn 3.93 Bn 12.23
3 Argenx Se 63.70 Bn 58.52 Bn 1.37 Bn 7.15
4 Moderna 57.56 Bn 52.42 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.05 Bn 44.05 Bn - -3.06
6 BeOne Medicines 40.16 Bn 35.06 Bn 1.53 Bn 2.05
7 Alnylam Pharmaceuticals 35.63 Bn 32.32 Bn 992.69 Mn 1.19
8 Royalty Pharma 28.63 Bn 27.79 Bn - 0.15
9 Insmed 27.73 Bn 26.57 Bn 358.27 Mn -0.06
10 OmniAb 582.15 Mn 530.16 Mn 12.81 Mn -0.05
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.05
Mar 31, 2026 -0.06
Dec 31, 2025 -0.12
Sep 30, 2025 -0.14
Jun 30, 2025 -0.15
Mar 31, 2025 -0.17
Dec 31, 2024 -0.13
Sep 30, 2024 -0.16
Jun 30, 2024 -0.13
Mar 31, 2024 -0.19
Dec 31, 2023 -0.14
Sep 30, 2023 -0.16
Jun 30, 2023 -0.15
Mar 31, 2023 -0.06
Dec 31, 2022 0.08
Sep 30, 2022 -0.07
Jun 30, 2022 -0.05
Mar 31, 2022 -0.16
Dec 31, 2021 0.00
Sep 30, 2021 -0.01